Nav: Home

Copper essential for burning fat, researchers find

June 10, 2016

Is copper deficiency contributing to the obesity epidemic?

Though small amounts of copper are essential to health - oysters, liver, beans and nuts are good sources - copper's role in metabolism has been unclear: Some studies found that it boosted fat burning, others that it depressed it.

University of California, Berkeley, Lawrence Berkeley National Laboratory and Howard Hughes Medical Institute researchers have now clarified the critical role that copper plays in nutrition: It helps move fat out of fat cells - called adipocytes - and into the blood stream for use as energy.

Without enough copper, fat builds up in fat cells without being utilized, said Christopher Chang, the Class of 1942 Chair and a professor of chemistry and of molecular and cell biology at UC Berkeley.

"Unlike other studies that link copper levels both to increased or decreased fat metabolism, our study shows definitively how it works - it's a signal that turns on fat cells," said Chang, who also is a faculty scientist at Berkeley Lab and a Howard Hughes Medical Institute investigator. "If we could find a way to burn fat more efficiently, this could be a big contribution to dealing with obesity and diabetes."

The new study appeared online this week, and will be published in the July print issue of the journal Nature Chemical Biology.

The findings point not only to a new role for copper in metabolism, but highlight the key role copper plays throughout the body. Previously, Chang showed that copper is a key signaling molecule in the brain, tamping down over-excitation of nerve cells.

"The work we have done with copper really shows that signaling is not restricted to just a few elements on the periodic table, like sodium, calcium and potassium," he said. "Copper is a brand new class; in a sense we have basically added a fourth letter to the alphabet, in terms of metal elements that contribute to the language of signaling."

The similar roles copper plays in regulating nerve cells and fat burning highlight a growing perception that the neurological system, specifically the brain, plays a role in diseases of metabolism and the immune system, such as obesity and inflammation.

"Some of us are now thinking about obesity as a neurological disease rather than strictly a metabolic disease, because there are potentially connections between your fat tissue and the brain," he said. "The notion that obesity and obesity-related diseases like diabetes may be neurological in nature opens the door to new basic science and therapeutic approaches."

Chang cautions against ingesting copper supplements as a result of these studies, however. Too much copper can lead to imbalances in other essential minerals, including zinc.

Copper-related diseases

With a longstanding interest in the biological roles of metals, Chang focused on fat metabolism after reading that copper is often given to cows to regulate weight gain. To discover how copper actually works in fat metabolism, he chose to study mice with a genetic defect that produces symptoms similar to those of a rare human illness, Wilson's disease. In both situations, a key enzyme that moves copper in and out of cells is mutated, causing misregulation and copper overload - often to toxic levels - in the liver. The condition is also characterized by bloated fat cells.

He and his team, in particular postdocs Lakshmi Krishnamoorthy and Joseph Cotruvo Jr., discovered that in the mice, copper is hoarded by the liver, basically starving fat cells of copper so that they cannot properly regulate fat storage and burning in organs such as the stomach and pancreas. This overload is accompanied by lower than normal levels of fats, or lipids, in the blood.

"Lipolysis is the breakdown of large pieces of fat into smaller pieces so they can circulate in the blood and be burned throughout the body," he said. "We discovered that in these Wilson's mice, low copper in the fat cells made them unable to burn fat as well as normal mice."

They succeeded in tracking down exactly how copper works: It releases a brake on fat burning. Normally, a second messenger molecule called cyclic-AMP (cAMP) activates the enzymes that break down the fat molecules. They found, however, that another enzyme (phosphodiesterase 3, or PDE3) blocks cAMP, probably to prevent fat breakdown when it is not needed, such as when we're couch potatoes. Copper blocks this enzyme, thereby "putting a brake on a brake," Chang said.

Chang is continuing his study of copper's roles in the brain and in fat metabolism, looking for possible ways to target the copper pathway to treat neurodegenerative brain diseases or diseases of metabolism. He also is looking at copper's roles in perception and sleep.

These studies have led him also to explore the connections between the central nervous system - the brain and spinal cord - and the peripheral nervous system, which innervates all our organs, and how that may cause disease.
-end-
The work was funded by the National Institutes of Health (GM 79465, GM067166, GM101502).

University of California - Berkeley

Related Diabetes Articles:

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.
Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
More Diabetes News and Diabetes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.